Yarrow Bioscience share price logo

Yarrow Bioscience

NASDAQ: YARW

$15.95

+0.35

(+2.24%)

Live

as on

Yarrow Bioscience Stock Performance

as on November 10, 2026 at 6:29 am IST

  • Day's Low

    Day's High

    $15.50
    $17.06
    downward going graph

    2.82%

    Downside

    6.96%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

Yarrow Bioscience share price movements today

Previous Close
$15.60
Open
$17.06
Volume
212.8K
Market Cap
$147.2M
Dividend Yield
128.85%
Day's Low - High
$15.50 - $17.06

Yarrow Bioscience Historical Returns

1 Month Return
-20.85 %
3 Month Return
-62.35 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Yarrow Bioscience Stock Fundamentals & Key Indicators

Check Yarrow Bioscience market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$147.2M

EPS (TTM)

-23.45

Dividend Yield

128.85%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.67

Industry PE ratio

-3.15

PEG Ratio

-0.01

EBITDA

-18.8M

Revenue (TTM)

482.0K

Profit Margin

97.51%

Return On Equity TTM

-70.23%

Yarrow Bioscience vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Yarrow Bioscience with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$147.2MNA-0.6797.51%128.85%
Neutral$101.5B7.32%-35.9528.00%0.00%
StrongBuy$46.5BNA66.6588.39%0.00%
StrongBuy$138.7B186.30%34.9485.57%0.00%
Buy$93.5B46.74%19.2685.77%0.41%

Analyst Recommendation on Yarrow Bioscience Stock

Based on 2 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 2 analysts, 100% of analysts recommend a 'BUY' rating for Yarrow Bioscience. Average target price of $58

Yarrow Bioscience Share Price Target

Get share price movements and forecasts by analysts on Yarrow Bioscience.

Current Price

$15.95

Analyzed by

2 Analysts

High

$60

0

Low

$56

Yarrow Bioscience target price $0, a slight upside of 0% compared to current price of $15.95. According to 2 analysts rating.

Indian Investors' Interest in Yarrow Bioscience Stock

Search interest for Yarrow Bioscience Stock has decreased by -85% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-85% versus previous 30 day period

Yarrow Bioscience Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
0
0
0
0
0
0
0
0
0
0
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
-7
-10
-13
-12
-9
-7
-7
-5
-3
-3
EBITDA
-6
-8
-12
-12
-8
-5
-7
-4
-3
-2
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
-
1
-
0
0
0
0
0
0
0
Income Before Tax
-6
-9
-12
-12
-8
-5
-7
-4
-3
-2
Income Tax Expense
-
-
-
0
-
-
-
0
-
-
Net Income
-6
-9
-12
-12
-8
-5
-7
-4
-3
-3
Net Profit Margin
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
93.02%
93.81%

Yarrow Bioscience Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
4
10
0
20
0
0
0
0
0
Gross Profit
4
10
0
19
0
0
0
0
0
Operating Income
-29
-54
-76
252
-38
-34
-29
-43
-29
EBITDA
-29
-54
-94
-251
-38
-33
-27
-39
-26
Interest Expense
-
-
0
4
5
-
-
-
-
Depreciation
0
0
0
0
0
0
-
0
0
Income Before Tax
-29
-51
-73
-255
-43
-33
-27
-39
-26
Income Tax Expense
0
-
-3
0
0
0
-
0
0
Net Income
-29
-51
-70
-255
-73
-23
-28
-39
-26
Net Profit Margin
100.00%
100.00%
20.99%
93.37%
100.00%
100.00%
100.00%
100.00%
95.96%

Yarrow Bioscience Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-6
-9
-12
-12
-8
-5
-7
-4
-3
-2
Operating Cash Flow
-7
-8
-8
-8
-11
-10
-7
-3
-4
-1
Investing Cash Flow
-3
19
-4
12
19
4
4
8
4
0
Financing Cash Flow
0
0
0
0
0
0
0
0
0
0
Change in Cash
-11
10
-13
3
8
-6
-2
4
0
-1

Yarrow Bioscience Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-29
-51
-73
-255
-73
-23
-28
-39
-26
Operating Cash Flow
-28
-52
-65
-137
-56
-29
-25
-33
-33
Investing Cash Flow
-15
-33
41
89
1
15
-57
23
37
Financing Cash Flow
49
125
4
61
39
1
82
0
0
Change in Cash
6
39
-18
13
-15
-11
0
-10
4

Global Institutional Holdings in Yarrow Bioscience

Check out the Institutions with significant holdings in Yarrow Bioscience.

Funds
Holdings
Steven Basta
5.69%
Vanguard
3.81%
David Domzalski
3.68%
MUTUAL FUND SERIES TRUST
2.84%
RTW Fund Group GP, LLC
2.82%

Yarrow Bioscience News & Key Events

  • img

    Today's Timeline - 10 September

    Fri, 01:35 AM

    -

    Yarrow Bioscience announces an underwritten public offering of common stock to fund R&D and corporate purposes.

    Fri, 02:08 AM

    -

    Yarrow updates strategy for thyroid autoimmune pipeline, highlighting YB-101 and Phase 2 trial for Graves disease.

Insights on Yarrow Bioscience

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 4 quarters, -7.28M → -3.00M (in $), with an average increase of 34.9% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 86.0K → 97.0K (in $), with an average increase of 11.3% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 265.7% return, outperforming this stock by 355.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 935.8% return, outperforming this stock by 947.2%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, YARW stock has moved down by -62.3%

About Yarrow Bioscience

Yarrow Bioscience is a clinical-stage biotechnology company focused on developing transformative therapies for autoimmune thyroid diseases. The Company's lead product candidate, YB-101, is a potential first-in-class anti-thyroid stimulating hormone receptor (TSHR) monoclonal antibody designed to directly and rapidly disrupt the central mechanism of both Graves' disease (GD) and thyroid eye disease (TED).
OrganisationYarrow Bioscience
Headquarters470 James Street, Suite 007, New Haven, CT, 06513, US
IndustryBiotechnology
CEORebecca Velez Frey

Key Management of Yarrow Bioscience

Name

Title

Ms. Rebecca Velez Frey Pharm.D.

President, CEO & Director

Mr. Tyler Zeronda CPA

Chief Financial Officer

Ms. Rachael Alford Ph.D.

Chief Operating Officer

Dr. Lori Payton Ph.D.

Chief Development Officer

Dr. Steven W. Ryder F.A.C.P, M.D.

Chief Medical Officer

FAQs

What is Yarrow Bioscience share price today?

Yarrow Bioscience share price today is $15.95 as on . Yarrow Bioscience share today touched a day high of $17.06 and a low of $15.50.

What is the 52 week high and 52 week low for Yarrow Bioscience share?

Yarrow Bioscience share touched a 52 week high of $0.00 on and a 52 week low of $0.00 on . Yarrow Bioscience stock price today i.e. is trending at $15.95,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Yarrow Bioscience's market capitalisation today?

Yarrow Bioscience market capitalisation is $0.00T as on .

How to invest in Yarrow Bioscience Stock (YARW) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Yarrow Bioscience on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Yarrow Bioscience Stock (YARW) from India?

Indian investors can start investing in Yarrow Bioscience (YARW) shares with as little as ₹93.92749786376953 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹939.27 in Yarrow Bioscience stock (as per the Rupee-Dollar exchange rate as on ). Based on Yarrow Bioscience share’s latest price of $15.95 as on November 10, 2026 at 12:59 am IST, you will get 0.6270 shares of Yarrow Bioscience. Learn more about fractional shares .